Quality Improvement for Institutions
www.cvquality.acc.org

ACC Public Reporting

Lead with Transparency. Lead with Quality.

Providing transparent, meaningful information about quality and outcomes allows facilities to highlight their strengths and stand out in a competitive landscape. ACC Public Reporting gives hospitals the opportunity to demonstrate their commitment to accountability, continuous improvement and high-quality cardiovascular care by voluntarily sharing performance data from select NCDR registries.

Click here to read ACC's Public Reporting Mission Statement

Why Participate?

ACC Public Reporting gives cardiovascular programs a powerful way to showcase clinical excellence, strengthen their brand, and build trust with patients.

Eligible Public Reporting Programs and Measures

Facilities participating in the following NCDR registries may elect to participate in ACC Public Reporting. Select a registry to view the measures available for public reporting.

  • Proportion of PCI Patients With Aspirin Prescribed at Discharge
  • Proportion of PCI Patients (who Received a Stent) With a P2Y12 Inhibitor Prescribed at Discharge
  • Proportion of PCI Patients With a Statin Prescribed at Discharge
  • Proportion of PCI Patients With Aspirin, Statin and/or P2Y12 inhibitor (if Eligible) Prescribed at Discharge
  • Quality of Care Composite: This is a weighted composite measure comprised of six component measures assessing mortality, bleeding, and acute kidney injury outcomes and guideline directed medical therapy, referral to cardiac rehabilitation, and PCI performed within 90 minutes for patients with acute myocardial infarctions
  • Proportion of ICD/CRT-D implant patients with left ventricular systolic dysfunction (LVSD), who were prescribed ACE-I or ARB or ARNI therapy, as eligible, at discharge.
  • Proportion of ICD/CRT-D implant patients with a prior MI who were prescribed beta-blocker therapy, as eligible, at discharge.
  • Proportion of ICD/CRT-D implant patients with left ventricular systolic dysfunction (LVSD) who were prescribed beta-blocker therapy, as eligible, at discharge.
  • Composite: Proportion of ICD/CRT-D implant patients prescribed all discharge medications (ACE-I/ARB/ARNI and beta-blocker) for which they were eligible.
  • Quality of Care Composite: Overall ranking of care, which is calculated using a statistical model with data from metrics 1546 (Composite: Proportion of ICD/CRT-D implant patients prescribed all discharge medications (ACE-I/ARB/ARNI and beta-blocker) for which they were eligible) and 2055 (Proportion of ICD/CRT-D patients that fulfill class I, IIa, or IIb guideline indications).
  • STEMI Performance Composite
  • Overall Defect Free Care Composite*

*Endorsed by the National Quality Forum

Connect Your Public Reporting Data to Patients

Publicly reported hospitals are featured in CardioSmart's Find Your Heart a Home tool, helping patients and caregivers find hospitals committed to cardiovascular quality improvement.

Ready to Get Started?

Join leading cardiovascular programs in demonstrating a commitment to transparency, quality and accountability through ACC Public Reporting.

To participate, complete the appropriate Consent Form (see below) and email the completed form to ncdr@acc.org. An ACC team member will follow up with next steps.


Temp Styles

American College of Cardiology: 2400 N St. NW, Washington DC 20006